Xenon Pharmaceuticals Inc.XENENASDAQ
LOADING
|||
Switch Symbol:
Gross Profit Growth Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Year-over-year gross profit growth rate
Latest
-12092.09%
↓ 2977% below average
Average (39q)
-392.94%
Historical baseline
Range
High:571.79%
Low:-12092.09%
CAGR
+16.9%
Consistent expansion
| Period | Value |
|---|---|
| Q3 2025 | -12092.09% |
| Q2 2025 | -108.43% |
| Q1 2025 | 0.00% |
| Q4 2024 | 0.00% |
| Q3 2024 | 0.00% |
| Q2 2024 | 100.00% |
| Q1 2024 | 0.00% |
| Q4 2023 | 0.00% |
| Q3 2023 | 0.00% |
| Q2 2023 | 0.00% |
| Q1 2023 | 0.00% |
| Q4 2022 | 100.00% |
| Q3 2022 | -35.58% |
| Q2 2022 | -103.98% |
| Q1 2022 | 41.63% |
| Q4 2021 | -68.57% |
| Q3 2021 | 33.37% |
| Q2 2021 | -35.22% |
| Q1 2021 | -21.73% |
| Q4 2020 | -249.79% |
| Q3 2020 | -51.03% |
| Q2 2020 | 89.09% |
| Q1 2020 | 112.62% |
| Q4 2019 | 153.26% |
| Q3 2019 | 23.81% |
| Q2 2019 | 10.20% |
| Q1 2019 | -2172.89% |
| Q4 2018 | 93.30% |
| Q3 2018 | -10.78% |
| Q2 2018 | 2.73% |
| Q1 2018 | 12.74% |
| Q4 2017 | 7.52% |
| Q3 2017 | -13.23% |
| Q2 2017 | -3.52% |
| Q1 2017 | -1699.73% |
| Q4 2016 | 571.79% |
| Q3 2016 | -209.86% |
| Q2 2016 | -77.24% |
| Q1 2016 | -88.27% |
| Q4 2015 | -27.59% |